Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Bisy GmbH has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single matter is being handled by 1 distinct examiner and is assigned to 1 distinct art unit. The limited scope of the current pending workload suggests a highly targeted approach to patent acquisition in this technical field. This administrative concentration means that the company's current efforts are focused on a single technical path within the patent office.
STEPHENS, AMELIA CAROLE is the busiest examiner for Bisy GmbH, with 1 busiest examiner pending action currently under review. This examiner manages the only active case for the company, so the 1 pending office action is entirely dependent on their individual review process. Practitioners should focus on the specific requirements of this 1 distinct examiner to move the application forward. Reviewing the examiner's past decisions in the 1 distinct art unit may provide a roadmap for overcoming potential rejections.
The 1 distinct art unit indicates that the technical subject matter is concentrated within a specific regulatory group. Since STEPHENS, AMELIA CAROLE is the only official involved in the pending office action, the prosecution strategy does not need to account for varying examiner behaviors. The 1 busiest examiner pending action constitutes the full extent of the company's current interactions with the patent office, making the outcome of this single matter the primary focus for the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEPHENS, AMELIA CAROLE | 1 | 85.7% | +33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270070 | NOVEL YEAST STRAINS | STEPHENS, AMELIA CAROLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270070 | NOVEL YEAST STRAINS | STEPHENS, AMELIA CAROLE | — |
| Art Unit | Apps |
|---|---|
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18270070 | NOVEL YEAST STRAINS | STEPHENS, AMELIA CAROLE | 1600 | §102§103§112 | Final Rejection | — | Pending | Jun 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial